CoChat

Development of the Rheumatoid Arthritis Symptom Questionnaire (RASQ): a patient reported outcome scale for measuring symptoms of rheumatoid arthritis

Banderas, Benjamin, Skup, Martha, Shields, Alan L., Mazar, Iyar, Ganguli, Arijit · 2017 · Current Medical Research and Opinion

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Rheumatoid arthritis (RA), a chronic, progressive inflammatory, autoimmune disease, can substantially reduce health-related quality of life (HRQoL) and lead to severe disability and early mortality. Patient-reported outcome (PRO) instruments are used to assess the patient experience of RA symptoms and impacts, and can capture RA treatment effects. To address limitations in existing PRO instruments, this research aimed to establish the content validity of a new instrument, the Rheumatoid Arthritis Symptom Questionnaire (RASQ), to assess the signs and symptoms of RA. METHOD: The most important and relevant sign and symptom concepts for RA patients were identified through a targeted review of the published literature, expert opinion, and concept elicitation patient interviews. Cognitive interviews were conducted with patients to test the comprehensibility and comprehensiveness of the RASQ. RESULTS: Seven symptoms emerged consistently across the conceptual research: joint pain, joint swelling, joint stiffness, joint tenderness, joint warmth, muscle pain, and tiredness. Draft item content was developed to assess these symptoms, in addition to a single impact item, resulting in three RASQ versions: two utilizing a 7 day recall period (one assessing symptoms at their worst, the other on average) and a third using a 24 hour recall period assessing symptoms at their worst. Cognitive interview results demonstrated patient understanding and ability to use the instrument. CONCLUSIONS: Content validity of the RASQ was established in accordance with instrument development guidelines. The RASQ fills a measurement gap by assessing the RA signs and symptoms most important to patients. Research evaluating the RASQ's psychometric properties is underway.

Overview

Integrity signals

Registry

Crossref · 10.1080/03007995.2017.1338562

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 10

  1. Gibofsky A., 2012, Am J Manag Care, 18, 295
  2. Centers for Disease Control and Prevention, 2013, Morb Mortal Wkly Rep, 62, 869
  3. Centers for Disease Control and Prevention, 2005, Morb Mortal Wkly Rep, 58, 421
  4. Finney A, 2010, Nurs Times, 106, 22
  5. US Department of Health and Human Services, Food and Drug Administration, 2009, Guidance for Industry: Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims
  6. Bruce B, 2005, Clin Exp Rheumatol, 23, S14
  7. Salaffi F, 2010, Clin Exp Rheumatol, 28, 186
  8. Leeb BF, 2008, J Rheumatol, 35, 1294
  9. van der Heijde DM, 1993, J Rheumatol, 20, 579
  10. Rindfleisch JA, 2005, Am Fam Physician, 72, 1037

Cited by

See all 11

Metadata

Authors
Banderas, B., Skup, M., Shields, A. L., Mazar, I., & Ganguli, A.
Affiliations
  • Adelphi Values, Boston, MA, USA;
  • AbbVie (United States) (US)
Corresponding author
Banderas, Benjamin
Venue
Current Medical Research and Opinion
Published
2017-06-22
Volume
33
Issue
9
Pages
1643-1651
ISSN
  • 0300-7995 (ISSN-L)
  • 1473-4877
OpenAlex
W2620717087
Cited by
10
References
29
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2021: 2 · 2018: 2 · 2017: 1
FWCI
0.72
Type
journal article
Language
en
Open access
closed
Locations
  • Current Medical Research and Opinion (publishedVersion)
  • PubMed (publishedVersion)
Funders
AbbVie Inc
Topics
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Health Sciences › Nursing › Research and Theory › Health Education and Validation
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
Keywords
rheumatoid arthritis, patient-reported outcome measures, symptom assessment, content validity, cognitive interviewing, joint pain, joint swelling, joint stiffness, myalgia, fatigue, symptom impact, health-related quality of life
MeSH terms
Patient Reported Outcome Measures, Adult, Aged, Arthritis, Rheumatoid, Female, Humans, Male, Middle Aged, Psychometrics, Quality of Life, Surveys and Questionnaires

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.